Your browser doesn't support javascript.
loading
P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas.
Roukas, Dimitrios; Kouzoupis, Anastasios; Spyropoulou, Despoina; Papanastasiou, George; Tsiambas, Evangelos; Tsouvelas, George; Falidas, Evangelos; Ragos, Vasileios; Peschos, Dimitrios; Manaios, Loukas; Katsinis, Spyros; Manoli, Arezina; Papouliakos, Sotirios; Lazaris, Andreas C; Kavantzas, Nikolaos.
Afiliação
  • Roukas D; Department of Psychiatry, 417 VA (NIMTS) Hospital, Athens, Greece.
  • Kouzoupis A; Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Spyropoulou D; Department of Radiation Oncology, Medical School, University of Patras, Patras, Greece.
  • Papanastasiou G; Department of Maxillofacial Surgery, School of Medicine, University of Ioannina, Ioannina, Greece.
  • Tsiambas E; Department of Maxillofacial Surgery, School of Medicine, University of Ioannina, Ioannina, Greece; tsiambasecyto@yahoo.gr.
  • Tsouvelas G; Department of Cytology, 417 VA (NIMTS) Hospital, Athens, Greece.
  • Falidas E; Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Ragos V; Department of Nursing, University of West Attica, Athens, Greece.
  • Peschos D; Department of Surgery, Halkida General Hospital, Halkida, Greece.
  • Manaios L; Department of Maxillofacial Surgery, School of Medicine, University of Ioannina, Ioannina, Greece.
  • Katsinis S; Department of Physiology, School of Medicine, University of Ioannina, Ioannina, Greece.
  • Manoli A; Department of Surgery, Bioclinic Medical Center, Athens, Greece.
  • Papouliakos S; Department of Otorhinolaryngology, Thoracic Diseases General Hospital "Sotiria", Athens, Greece.
  • Lazaris AC; Department of Otorhinolaryngology, Thoracic Diseases General Hospital "Sotiria", Athens, Greece.
  • Kavantzas N; Department of Otorhinolaryngology, Thoracic Diseases General Hospital "Sotiria", Athens, Greece.
In Vivo ; 36(5): 2205-2210, 2022.
Article em En | MEDLINE | ID: mdl-36099147
BACKGROUND/AIM: Meningiomas represent the main intracranial primary central nervous system (CNS) tumour in adults worldwide. Oncogenes' over-activation combined with suppressor genes' silencing affect negatively the biological behavior of these neoplasms. This study aimed to explore the impact of p53 suppressor gene expression in meningiomas' clinic-pathological features based on a combination of sophisticated techniques. MATERIALS AND METHODS: Fifty (n=50) meningiomas were included in the study, comprising a broad spectrum of histopathological subtypes. An immunohistochemistry assay was applied on tissue microarray cores followed by digital image analysis. RESULTS: p53 protein over-expression (high staining intensity levels) was observed in 27/50 (54%) cases, whereas the rest (23/50-/46%) demonstrated moderate to low levels of the protein. p53 over-expression was statistically significantly correlated to the mitotic index of the examined cases (p-value=0.001). Interestingly, the atypical/anaplastic group of histotypes demonstrated the strongest p53 expression rates compared to the others (p-value=0.001). CONCLUSION: p53 overexpression is observed in a broad spectrum of meningiomas. High expression levels lead to an aggressive biological behavior of the malignancy (combined with increased mitotic rates), especially in atypical and anaplastic sub-types that also have a high recurrence rate.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Meníngeas / Meningioma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Meníngeas / Meningioma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article